CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $86,000 | -42.3% | 32,200 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $149,000 | -17.7% | 34,467 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $181,000 | -21.3% | 35,498 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $230,000 | -17.0% | 36,342 | +1.2% | 0.00% | 0.0% |
| Q1 2021 | $277,000 | +61.0% | 35,899 | +36.8% | 0.00% | 0.0% |
| Q4 2020 | $172,000 | -4.4% | 26,244 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $180,000 | -21.7% | 26,996 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $230,000 | +12.7% | 27,611 | +3.6% | 0.00% | 0.0% |
| Q1 2020 | $204,000 | -12.8% | 26,654 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $234,000 | +11.4% | 28,195 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $210,000 | -34.6% | 28,433 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $321,000 | +5.2% | 28,631 | +0.9% | 0.00% | 0.0% |
| Q1 2019 | $305,000 | -31.0% | 28,383 | -3.1% | 0.00% | -50.0% |
| Q4 2018 | $442,000 | -19.0% | 29,303 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $546,000 | -4.9% | 29,529 | +17.5% | 0.00% | 0.0% |
| Q2 2018 | $574,000 | +8.7% | 25,122 | +35.3% | 0.00% | 0.0% |
| Q1 2018 | $528,000 | +27.8% | 18,571 | -5.1% | 0.00% | +100.0% |
| Q4 2017 | $413,000 | +16.7% | 19,569 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $354,000 | +26.9% | 19,477 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $279,000 | +28.6% | 18,021 | +43.3% | 0.00% | 0.0% |
| Q1 2017 | $217,000 | +68.2% | 12,580 | +7.1% | 0.00% | – |
| Q4 2016 | $129,000 | -99.9% | 11,746 | -0.3% | 0.00% | -100.0% |
| Q3 2016 | $184,663,000 | +53.7% | 11,777 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $120,118,000 | +110.7% | 11,759 | +165.7% | 0.00% | – |
| Q1 2016 | $57,000,000 | – | 4,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |